Hepatitis B Virus Genotype E/A Recombinants from Blood Donors in Beira, Mozambique-Reference-Cited by-同舟云学术

Hepatitis B Virus Genotype E/A Recombinants from Blood Donors in Beira, Mozambique

Published:2023-06-20 Issue:6 Volume:12 Page:
ISSN:2576-098X
Container-title:Microbiology Resource Announcements
language:en
Short-container-title:Microbiol Resour Announc

Author:

Tyler Barbara¹,Meeds Heidi L.¹,Odegard Elizabeth A.¹,Ismael Nalia²,Vubil Adolfo²,Zicai Ana Flora²,Mabunda Nédio²,Blackard Jason T.¹^ORCID

Affiliation:

1. Division of Digestive Diseases, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA

2. Instituto Nacional de Saúde, Marracuene, Mozambique

Abstract

Hepatitis B virus (HBV) is endemic in many parts of sub-Saharan Africa. Here, we present 5 full-length HBV recombinant genomes from blood donors in Beira, Mozambique. The genomes are recombinants between genotypes E and A and are distantly related to one another, based on their genetic distances.

Funder

National Research Fund of Mozambique

HHS | NIH | National Institute of Environmental Health Sciences

Publisher

American Society for Microbiology

Subject

Genetics,Immunology and Microbiology (miscellaneous),Molecular Biology

Link

https://journals.asm.org/doi/pdf/10.1128/mra.00182-23

Reference22 articles.

1. Hepatitis B virus intergenotypic recombinants worldwide: An overview

2. HBV evolution and genetic variability: Impact on prevention, treatment and development of antivirals

3. Molecular identification of hepatitis B virus genotypes/subgenotypes: Revised classification hurdles and updated resolutions

4. A new subtype (subgenotype) Ac (A3) of hepatitis B virus and recombination between genotypes A and E in Cameroon

5. Deletions and recombinations in the core region of hepatitis B virus genotype E strains from asymptomatic blood donors in Guinea, west Africa

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Oxford Nanopore Technology-Based Hepatitis B Virus Sequencing Protocol Suitable For Genomic Surveillance Within Clinical Diagnostic Settings;2024-01-20